medigraphic.com
SPANISH

Revista Cubana de Investigaciones Biomédicas

ISSN 1561-3011 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 4

<< Back

Rev Cubana Invest Bioméd 2021; 40 (4)

Rashless mucositis induced by Mycoplasma pneumoniae. First case reported in Peru

Hueda ZM, Copaja CC, Bardales SF, Finkelstein BB
Full text How to cite this article

Language: Spanish
References: 17
Page: 1-8
PDF size: 198.31 Kb.


Key words:

Mycoplasma pneumonia, stomatitis, Mycoplasma, mucositi.

ABSTRACT

Introduction: Mycoplasma pneumoniae is a bacterium of worldwide distribution which commonly causes respiratory infections such as tracheobronchitis and atypical pneumonia. It has recently been described as etiology of a disease called Mycoplasma pneumoniae-induced rash and mucositis.
Objective: Present the first known report of Mycoplasma pneumoniae-associated mucositis in Peru, diagnosed by compatible clinical picture and confirmed by serology.
Clinical case: A male 11-year-old patient from the Tacna Region in Peru presented with a clinical state of four days' evolution characterized by fever, coughing, dyspnea, bilateral purulent conjunctivitis and very painful erosive lesions on the jugal mucosa, tongue and lips. The patient received antibiotic, antiviral and antifungal treatment, to which he responded favorably. Mycoplasma pneumoniae infection was confirmed by IgM ELISA serology.
Conclusions: Early recognition of this syndrome will lead to a more specific treatment, avoiding the restriction of appropriate drugs.


REFERENCES

  1. Bennett JE., Dolin R, Blaser MJ. Enfermedades Infecciosas: Principios y práctica. 8th ed. Barcelona: ElSevier; 2016.

  2. Hanukoglu A, Hebroni S, Fried D. Pulmonary involvement in Mycoplasma pneumoniae infection in families. Infection. 1986;14:1-6. Doi: 10.1007/978-1-4615-5327-4_25

  3. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697-728. Doi: 10.1128/CMR.17.4.697-728.2004

  4. Santos RP, Silva M, Vieira AP, Brito C. Mycoplasma pneumoniae-induced rash and mucositis: a recently described entity. BMJ Case Rep. 2017. Doi: 10.1136/bcr-2017-220768

  5. Martinez Pérez M, Imbernón Moya A, Lobato Berezo A, Churruca Grijelmo M. Mycoplasma pneumoniae-induced mucocutaneous rash: a new syndrome distinct from erythema multiforme? Report of a new case and review of the literature. Actas Dermosifiliogr. 2016;107:e47-e51. Doi: 10.1016/j.adengl.2016.06.005

  6. Vujic I, Shroff A, Grzelka M, Posch C, Monshi B, Sanlorenzo M, et al. Mycoplasma pneumoniae-associated mucositis-case report and systematic review of literature. J Eur Acad Dermatol Venereol. 2015;29:595-598. Doi: 10.1111/jdv.12392

  7. Šternberský J, Tichý M. Fuchs’ syndrome (Stevens-Johnson syndrome without skin involvement) in an adult male--a case report and general characteristics of the sporadically diagnosed disease. Acta Dermatovenerol Croat 2014;22:284-7. PMDI: 25580788

  8. Kheiri B, Alhesan NA, Madala S, Assasa O, Shen M, Dawood T. Mycoplasma pneumoniae-associated Fuchs syndrome. Clin Case Rep. 2017;6(2):434-435. Doi: 10.1002/ccr3.1350

  9. Ting CY, Shahdadpuri R. Fuchs syndrome: a case of fever, mucositis and conjunctivitis. BMJ Case Rep. 2018;2018. pii: bcr-2017-223321. Doi: 10.1136/bcr-2017-223321

  10. C, Zão I, Ribeiro F, Rocha V, Neto P, Matias Jesus G. Mycoplasma pneumoniae-associated Mucositis: A Recently Described Entity. Eur J Case Rep Intern Med. 2018;5(11):000977. Doi:10.12890/2018_000977

  11. Martínez M, Ruiz M, et al. Detection of Mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008 Dec;57(Pt 12):1491-1495. DOI: 10.1099/jmm.0.2008/003814-0.

  12. Qu, J., Gu, L., Wu, J. et al. Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC Infect Dis. 2013;13-172. Doi: 10.1186/1471-2334-13-172.

  13. Canavan TN, Mathes EF, Frieden I, Shinkai K. Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol. 2015;72(2):239-45. Doi: 10.1016/j.jaad.2014.06.026.

  14. Yachoui R, Kolasinski SL, Feinstein DE. Mycoplasma pneumoniae with atypical Stevens-Johnson syndrome: A diagnostic challenge. Case Rep Infect Dis 2013;2013:457161. Doi: 10.1155/2013/457161.

  15. Latsch K, Girschick HJ, Abele-Horn M. StevensJohnson syndrome without skin lesions. J Med Microbiol 2007;56:1696-9. Doi: 10.1099/jmm.0.47318-0

  16. Schalock PC, Dinulos JGH. Mycoplasma pneumoniaee induced cutaneous disease. Int J Dermatol. 2009;48(7):673-680. Doi: 10.1111/j.1365-4632.2009.04154.x.

  17. Li HO, Colantonio S, Ramien ML. Treatment of Mycoplasma pneumoniae-Induced Rash and Mucositis With Cyclosporine. J Cutan Med Surg. 2019 Nov/Dec;23(6):608-612. Doi: 10.1177/1203475419874444.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Invest Bioméd. 2021;40